Determination of a Safe Dose of Optison in Pediatric Patients With Solid Tumors

Completed · Phase 1

Conditions studied: Abdominal Neoplasms, Pelvic Neoplasms

In brief

St. Jude Children's Research Hospital is studying ways to make ultrasound images clearer - to be able to see blood vessels, body structures, and tumors better. Ultrasound uses sound waves to create pictures, allowing doctors and other medical professionals to "see" inside the body. Researchers are studying a contrast agent (like a dye) called Optison™. St. Jude Children's Research Hospital researchers want to learn the best and safest dose of this ultrasound "dye."

Key facts

Study ID

NCT00186953

Run by

St. Jude Children's Research Hospital

People needed

14

Starts

2002-06-01

Expected to finish

2004-08-01

Last updated by the study team

2011-09-20

Who can join

Age: 2 and older, up to 20. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age: 2-20 years old
• Subject has a known or suspected solid soft tissue tumor in the abdomen or pelvis.
• Subject is scheduled for other imaging or is already scheduled for an ultrasound or has already had adequate imaging performed at an outside institution.
• Subject is able to lie still for the exam without sedation.

You may not qualify if…

• Known or suspected hypersensitivity to albumin, blood or blood products.
• History of open heart surgery, cyanotic congenital heart disease or an axygen saturation of less than 96% as determined by pulse oximetry.

Where it is running

• St. Jude Children's Research Hospital — Memphis, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.